Agenus Inc.
AGENNASDAQHealthcare● Active
$3.14
$-0.09(-2.79%)
Market Cap$130757136
P/E Ratio—
52W High$7.34
52W Low$2.71
Agenus Inc. (AGEN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AGEN · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 11, 2026EPS Actual
$1.02
Est. $2.10 · -51.4%
Revenue
$0.03B
Est. $0.13B · -74.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 11, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
AGEN reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.03
Rev. $1.54B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.03
Rev. Est.$1.54B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 10, 2026 | $0.06 | — | — | — | $0.03B | — |
| ▼ Q2 FY2026 | May 11, 2026 | $2.10 | $1.02 | -51.4% | $0.03B | $0.13B | -74.0% |
| ▲ Q1 FY2026 | Mar 16, 2026 | -$1.27 | $0.56 | +144.1% | $0.03B | $0.03B | +21.7% |
| ▼ Q4 FY2025 | Nov 10, 2025 | $2.63 | $1.94 | -26.2% | $0.03B | $0.03B | +7.6% |
| ▼ Q3 FY2025 | Aug 11, 2025 | -$0.78 | -$1.00 | -28.2% | $0.03B | $0.02B | +2.9% |
| ▲ Q2 FY2025 | May 12, 2025 | -$1.61 | -$1.03 | +36.0% | $0.02B | $0.02B | +8.9% |
| ▲ Q1 FY2025 | Mar 11, 2025 | -$2.36 | -$2.04 | +13.6% | $0.03B | $0.03B | -10.8% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -$2.33 | -$3.08 | -32.2% | $0.03B | $0.03B | -21.1% |
Q3 FY2026
Aug 10, 2026
EPS Actual
—
EPS Est.
$0.06
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 11, 2026Miss
EPS Actual
$1.02
EPS Est.
$2.10
EPS Surpr.
-51.4%
Revenue
$0.03B
Q1 FY2026
Mar 16, 2026Beat
EPS Actual
$0.56
EPS Est.
-$1.27
EPS Surpr.
+144.1%
Revenue
$0.03B
Q4 FY2025
Nov 10, 2025Miss
EPS Actual
$1.94
EPS Est.
$2.63
EPS Surpr.
-26.2%
Revenue
$0.03B
Q3 FY2025
Aug 11, 2025Miss
EPS Actual
-$1.00
EPS Est.
-$0.78
EPS Surpr.
-28.2%
Revenue
$0.03B
Q2 FY2025
May 12, 2025Beat
EPS Actual
-$1.03
EPS Est.
-$1.61
EPS Surpr.
+36.0%
Revenue
$0.02B
Q1 FY2025
Mar 11, 2025Beat
EPS Actual
-$2.04
EPS Est.
-$2.36
EPS Surpr.
+13.6%
Revenue
$0.03B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
-$3.08
EPS Est.
-$2.33
EPS Surpr.
-32.2%
Revenue
$0.03B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-1.13 | $-0.90 | $-0.67 | 1 |
| Q3 FY2027 | $-1.15 | $-0.91 | $-0.68 | 1 |
| Q2 FY2027 | $-1.14 | $-0.91 | $-0.68 | 1 |
| Q1 FY2027 | $-1.12 | $-0.89 | $-0.67 | 1 |
| Q4 FY2026 | $0.03 | $0.04 | $0.05 | 1 |
| Q3 FY2026 | $0.04 | $0.05 | $0.06 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 11, 2026 | -51.4% | $3.82 | $3.26 | -14.66% |
| ▲ Q1 FY2026 | Mar 16, 2026 | +144.1% | $3.10 | $3.29 | +6.13% |
| ▼ Q4 FY2025 | Nov 10, 2025 | -26.2% | $3.98 | $4.21 | +5.78% |
| ▼ Q3 FY2025 | Aug 11, 2025 | -28.2% | $4.80 | $4.27 | -11.04% |
| ▲ Q2 FY2025 | May 12, 2025 | +36.0% | $2.91 | $3.50 | +20.27% |
| ▲ Q1 FY2025 | Mar 11, 2025 | +13.6% | $2.15 | $2.05 | -4.65% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -32.2% | $3.90 | $3.11 | -20.26% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -75.0% | $5.08 | $5.28 | +3.94% |
Q2 FY2026-14.66%
Report Date
May 11, 2026
EPS Beat/Miss
-51.4%
Price Before
$3.82
Price After
$3.26
Q1 FY2026+6.13%
Report Date
Mar 16, 2026
EPS Beat/Miss
+144.1%
Price Before
$3.10
Price After
$3.29
Q4 FY2025+5.78%
Report Date
Nov 10, 2025
EPS Beat/Miss
-26.2%
Price Before
$3.98
Price After
$4.21
Q3 FY2025-11.04%
Report Date
Aug 11, 2025
EPS Beat/Miss
-28.2%
Price Before
$4.80
Price After
$4.27
Q2 FY2025+20.27%
Report Date
May 12, 2025
EPS Beat/Miss
+36.0%
Price Before
$2.91
Price After
$3.50
Q1 FY2025-4.65%
Report Date
Mar 11, 2025
EPS Beat/Miss
+13.6%
Price Before
$2.15
Price After
$2.05
Q4 FY2024-20.26%
Report Date
Nov 12, 2024
EPS Beat/Miss
-32.2%
Price Before
$3.90
Price After
$3.11
Q3 FY2024+3.94%
Report Date
Aug 8, 2024
EPS Beat/Miss
-75.0%
Price Before
$5.08
Price After
$5.28
Avg Beat Reaction+7.25%
Avg Miss Reaction-7.25%
Beat Rate3 / 8 quarters
Largest Move+20.27% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AGEN ends December
Agenus Inc. (AGEN) most recently reported earnings on May 11, 2026 for Q2 FY2026, posting EPS of $1.02 — missing the analyst consensus of $2.10 by -51.4%. The next AGEN earnings date is expected around September 1, 2026.
Each quarter, investors track AGEN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AGEN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AGEN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AGEN earnings · 5 questionsAgenus Inc.'s next earnings report is expected around September 1, 2026. AGEN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AGEN historically reports after market close (AMC).
AGEN earnings datewhen is AGEN earningsAGEN next earnings datewhen does AGEN report earningsAGEN earnings calendar
▸ Source: FMP · Agenus Inc. SEC filings · US GAAP · Agenus Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026